Registration Details
This event is part of a series of Technology Partn3Ring webinars focusing on new approach methodologies (NAMs), which are replacement technologies for use in assessing chemical or drug toxicity.
The second NAMs webinar will include presentations from researchers working across human relevant in vitro technologies, ranging from brain tumour modelling, stem cell platforms in toxicity and imaging, cell-based assays in safety assessment and organ function studies.
Learn more about the NAMs Technology Partn3Ring webinar series, including other upcoming sessions and previous recordings.
Speakers and topics
Amrita Singh (Integral Molecular)
- Human-relevant membrane proteome array to assess off-target binding of antibody-based therapies early in development.
- Seeking new users and applications of the technology to expand 3Rs benefits.
Davide Danovi (Migration Biotherapeutics)
- Human iPSC-based neural spheroid platform modelling tumour-brain interactions in glioblastoma.
- Looking for collaborators to further develop the model and quantify cancer cell migration.
Ciara Doran (Sansanima Limited)
- Non-animal, cell‑based assays for safety and potency testing of Clostridials.
- Seeking partners for quality, process control or next generation development of botulinum toxin.
James L. Sherley (Asymmetrex® LLC)
- Rapid, accurate counting and monitoring of tissue stem cells in heterogeneous tissue cell preparations used in in vitro drug toxicity assessment.
- Seeking collaborators to help assess predictive value of technology in drug candidates known to cause chronic organ failure.
Jiwu Wang (Allele Biotechnology)
- Bioprinted iPSC derived liver mini-organs to replace in vivo organ function studies in drug development.
- Seeking teams with liver specific assay expertise to further qualify the model in longitudinal studies.
About Technology Partn3Ring webinars
The NC3Rs Technology Partn3Ring webinars showcase technologies with 3Rs potential to the wider scientific community to identify new partners for further development and use. Open to researchers, clinicians, pharmaceutical and industry professionals, each webinar features short pitches outlining 3Rs research, tools and technologies. Attendees can ask questions and connect with the speakers to access unique collaboration opportunities.